In keeping with the traditions of Mesoblast, does anybody want to initiate a guessing game of when the Revascor announcement will drop?
I wouldn't mind something along the lines shown below.....dropping tomorrow, being Thursday, also in keeping with the Mesoblast tradition.
Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that U.S. FDA has informed the company that the FDA supports submission of a proposed Biologics License Application (BLA) for accelerated approval of Revascor® (rexlemestrocel-L) in the treatment of patients with ischemic chronic heart failure with reduced ejection fraction (HFrEF) and inflammation.
Mesoblast intends to file the BLA this calendar year.
MSB Price at posting:
$1.76 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)